Ever Source Wealth Advisors, LLC Maxcyte, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 475 shares of MXCT stock, worth $1,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
475
Previous 114
316.67%
Holding current value
$1,021
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$21.6 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$17.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$10.8 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $219M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...